EmaCure® is a next-generation, blood-derived therapeutic system based on research carried out at the Technische Universität München. Using this system, clinicians can develop personalised therapies to meet their patients' needs in the areas of wound repair and regeneration.
March 2016 EmaCure wins Science4Life Award
Oct. 2015 EmaCure presented at the DGPRÄC Congress in Berlin
May 2015 EmaCure presented at the 60th PSRC Meeting in Seattle
Sept. 2014 EmaCure presented at the DGPRÄC / VDÄPC /ÖGPÄRC Congress in Munich
May 2014 EmaCure presented at the 3rd EURAPS Research Counsil Meeting in Ischia, winning award for best scientific work
March 2014 EmaCure is awarded the TUM IdeAward 2014 for best scientific idea with market potential
Nov. 2013 Prof.A.F.Schilling to present EmaCure at TUM-IAS, Scientists meet Scientists (20.11.13 at 13.15pm)
Oct. 2013 EmaCure presented at the 1st Wund-D.A.CH 3-country Congress in Friedrichshafen, winning the Prize for best scientific work (awarded to Mr P.Moog).
Aug. 2013 Publication of international patent application on a device for preparing and delivering the EmaCure therapy.
May 2013 Prof. A.F.Schilling and Dr E.Hadjipanayi are awarded the Innovation Prize for their work on the EmaCure therapy, at the German Symposium for Biotechnology (Deutsche Biotechnologietage) in Stuttgart
May 2013 EmaCure presented at the International Investigative Dermatology (IID) Congress 2013 in Edinburgh
April 2013 ESDR (European Society for Dermatological Research) Grant awarded to Mrs. A.T.Bauer for her participation in the IID (International Investigative Dermatology) Congress 2013 in Edinburgh.
March 2013 EmaCure presented at the 17th World Congress of the International Confederation for Plastic, Reconstructive and Aesthetic Surgery (IPRAS) in Santiago
Feb.2013 International patent (PCT) application filed on a device for preparing and delivering the EmaCure therapy
Nov. 2012 Scientists working on the EmaCure therapy receive Best Paper Award at the IPRAS-TA/10th IQUAM Congress and Consensus Conference in Athens
Sept. 2012 EmaCure presented at the 3rd World Congress of Tissue Engineering and Regenerative Medicine (TERMIS) in Vienna